NCT06999304
Pilot TMS in Mild TBI
Enrolling by Invitation
NAAges 18–65InterventionalTreatmentHealthPartners InstituteInvestigator-initiated
~20 participants
Updated 2026-07-22 on ClinicalTrials.gov
What's tested:Intermittent theta burst stimulation
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Percentage of participants with anomalous parcellations - developing the method of personalization of TMS for PPCS
Measured over baseline
+3 more outcomes measured
Conditions
Where it's being run
1 sites across 1 statesMinnesota1
Study leadership
- Bhavani Kashyap, MBBS, PhD · PRINCIPAL_INVESTIGATOR · HealthPartners Institute
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Percentage of participants with anomalous parcellations - developing the method of personalization of TMS for PPCSbaseline
Percentage of participants matched with anomalous parcellations based on one of the 2 top ranked burdensome symptoms/symptom profile. If an anomalous parcellation matching one of the top 2 ranked symptom profiles can be identified in at least 16 out of 20 (80%) of participants, the trial will be considered a success.
- Anomalous parcellations - developing the method of personalization of TMS targets for PPCSbaseline
Names and number of anomalous parcellations identified using connectivity analysis and targets available to treat with TMS based on symptom profiles
- Distribution of complaints for PPCSbaseline
Distribution of chief symptom/complaints among participants measured by concussion clinical profile (CP) screen
- Mapping of complaints to anomalous parcellationsbaseline
Mapping of chief symptom/complaints to parcellations based on literature and connective abnormalities